INS and breast carcinoma: In the study on the relationship between insulin intake and breast cancer mortality in diabetic patients, it was found that the group receiving insulin had a 1.22 (95% CI: 1.05–1.42; P-value = 0.009) times higher risk of breast cancer mortality compared to those not receiving insulin (Fig 2).